Nutritional advice

Objectives:
Probiotics are being used increasingly in pregnant women, whereas the efficiency on pregnancy outcomes is yet lacking. Therefore, this review article has been conducted.

Have probiotic supplements during pregnancy positive effects on pregnancy outcomes, such as eczema, gestational age?

Study design:
This review article included 18 RCTs with a total of 4,356 pregnant women.

Results and conclusions:
The investigators found probiotic supplementation during pregnancy significantly decreased risk of atopic eczema with 32% [RR = 0.68, 95% CI = 0.58 to 0.81, p 0.001, without significant heterogeneity].

The investigators found probiotic supplementation during pregnancy significantly decreased risk of eczema with 21% [RR = 0.79, 95% CI = 0.68 to 0.91, p = 0.002, without significant heterogeneity].

The investigators found probiotic supplementation during pregnancy was associated with a prolonged gestational age [WMD = 0.09, 95 % CI = 0.04 to 0.15, p = 0.001 with insignificant heterogeneity].
However, probiotic supplementation during pregnancy had no significant effect on birth weight [p = 0.851].

The investigators found probiotic supplementation during pregnancy significantly decreased risk of death with 66% [RR = 0.34, 95% CI = 0.13 to 0.91, p = 0.031, without evidence of heterogeneity].

The investigators found probiotic supplementation during pregnancy significantly decreased risk of necrotising enterocolitis (NEC) with 62% [RR = 0.38, 95% CI = 0.18 to 0.11, p = 0.012, without evidence of heterogeneity].

The investigators concluded probiotic supplementation in pregnant women is beneficial for atopic eczema, eczema, gestational age, death and necrotising enterocolitis.

Original title:
Effect of probiotic supplementation in pregnant women: a meta-analysis of randomised controlled trials by Kuang L and Jiang Y.

Link:
https://www.ncbi.nlm.nih.gov/pubmed/31856928

Additional information of El Mondo:
Find more information/studies on probiotic and pregnancy right here.

Necrotizing enterocolitis (NEC) is a devastating disease that affects mostly the intestine of premature infants. The wall of the intestine is invaded by bacteria, which cause local infection and inflammation that can ultimately destroy the wall of the bowel (intestine). Such bowel wall destruction can lead to perforation of the intestine and spillage of stool into the infant’s abdomen, which can result in an overwhelming infection and death.
 

Objectives:
Do higher gestational vitamin D levels (vitamin D levels of the mother during pregnancy) decrease risk of multiple sclerosis (MS) in offspring?

Study design:
This review article included 4 case-control studies of moderate to low risk of bias.

Factors identified as determinants of heterogeneity were the definitions of vitamin D deficiency, the characteristics of study participants and the quality of the study.

Results and conclusions:
The investigators found that higher levels of gestational vitamin D significantly reduced risk of multiple sclerosis in offspring with 37% [OR = 0.63, 95% CI = 0.47 to 0.84] in random effects models and in a stratified analysis based on study quality.

The investigators concluded higher levels of gestational vitamin D reduce risk of multiple sclerosis in offspring.

Original title:
Gestational vitamin D and offspring risk of multiple sclerosis: a systematic review and meta-analysis by Jasper EA, Nidey NL, […], Ryckman KK.

Link:
https://www.ncbi.nlm.nih.gov/pubmed/32014337

Additional information of El Mondo:
Find more information/studies on vitamin D and pregnancy right here.

 

Objectives:
Micronutrients’ deficiency is a common phenomenon among a majority of the population residing in the low- and middle-income countries (LMICs) especially among women and children. Given the widespread prevalence of micronutrients’ deficiency in LMICs, iron-fortified foods could be of potential benefits for both the mother and the development of fetus. Therefore, this review article has been conducted.

Does iron fortification increase hemoglobin (Hb) concentration during pregnancy and have iron fortification positive effects on specific maternal and pregnancy outcomes?

Study design:
This review article included 12 RCTs (n = 3,872).

The weighted mean difference (WMD) and relative risk (RR) were calculated using random-effects models. Sources of heterogeneity were explored through meta-regression.

The funnel plot was symmetrical, indicating that there was absence of any publication bias which was confirmed using Egger's weighted regression method [Egger test, ρ = 0.69].

Results and conclusions:
The investigators found the mean change in hemoglobin concentration was significantly higher in the group of mothers with iron fortification when compared with the control group [WMD = 4.45 g/L, 95% CI = 2.73 to 6.17 g/L, I2 = 83%, ρ 0.00001].

The investigators found in meta-regression analysis that the duration of feeding was positively associated with the effect size.

The investigators concluded iron fortification increases hemoglobin (Hb) concentration during pregnancy. Further research is required to explore the benefits of iron fortification on maternal and neonatal health outcomes during pregnancy.

Original title:
Meta-analysis Approach on Iron Fortification and Its Effect on Pregnancy and Its Outcome Through Randomized, Controlled Trials by Athe R, Dwivedi R, […], Banset U.  

Link:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114015/

Additional information of El Mondo:
Find more information/studies food fortification and iron right here.

Objectives:
Omega-3 fatty acid and vitamin E or D co-supplementation may be an important approach to improve metabolic status in gestational diabetes, but the results are conflicting. Therefore, this review article has been conducted.

Do omega-3 fatty acid and vitamin E or D co-supplementation improve metabolic status in gestational diabetes?

Study design:
This review article included 4 RCTs.

Results and conclusions:
The investigators found omega-3 fatty acid and vitamin E or D co-supplementation was associated with a significantly reduced fasting plasma glucose level [MD = -10.47, 95% CI = -15.33 to -5.61, p  0.0001], homeostasis model of assessment-insulin resistance level [MD = -1.6, 95% CI= -2.44 to -0.77, p = 0.0002], malondialdehyde level [MD = -1.00, 95% CI = -1.05 to -0.95, p  0.00001] and triglycerides level [MD = 26.22, 95% CI = -38.94 to -13.51, p  0.0001].

The investigators found omega-3 fatty acid and vitamin E or D co-supplementation was associated with a significantly increased antioxidant capacity level [MD = 173.51, 95% CI = 164.72-182.30, p  0.00001].

The investigators found omega-3 fatty acid and vitamin E or D co-supplementation showed no effect on nitric oxide level [MD = 5.95, 95% CI = -7.48 to 19.37, p = 0.39] or total cholesterol level [MD = 1.63, 95% CI = -13.46 to 16.72, p = 0.83].

The investigators concluded omega-3 fatty acid and vitamin E or D co-supplementation have a favourable effect on metabolic status in gestational diabetes.

Original title:
Influence of omega-3 fatty acid and vitamin co-supplementation on metabolic status in gestational diabetes: A meta-analysis of randomized controlled studies by Li F, Pei L, […], Ye H.

Link:
https://www.ncbi.nlm.nih.gov/pubmed/32145487

Additional information of El Mondo:
Find more information/studies on diabetes, pregnancy, omega-3 fatty acid, vitamin D and E right here.

Objectives:
The efficacy of n-3 fatty acids supplementation on the prevention of pregnancy-induced hypertension or preeclampsia remains unclear. Therefore, this meta-analysis (systematic review) has been conducted.

Does n-3 fatty acids supplementation (EPA and/or DHA and/or ALA) decrease risk of pregnancy-induced hypertension and preeclampsia during pregnancy?

Study design:
This review article included 14 RCTs.

Results and conclusions:
The investigators found that n-3 fatty acids supplementation significantly reduced risk of preeclampsia with 18% [RR = 0.82, 95% CI = 0.70 to 0.97, p = 0.024. I2 = 19.0%].
However, n-3 fatty acids supplementation did not associated with a reduced risk of pregnancy-induced hypertension [RR = 0.98, 95% CI = 0.90 to 1.07, p = 0.652, I2 = 0%].

The investigators concluded n-3 fatty acids supplementation (EPA and/or DHA and/or ALA)  reduces risk of preeclampsia during pregnancy.

Original title:
Efficacy of n-3 fatty acids supplementation on the prevention of pregnancy induced-hypertension or preeclampsia: A systematic review and meta-analysis by Bakouei F, Delavar MA, […], Taheri Z.

Link:
https://www.ncbi.nlm.nih.gov/pubmed/32039806

Additional information of El Mondo:
Find more information/studies on n-3 fatty acids, hypertension and pregnancy right here.